Dalacin-T Gel Post Approval Study
Dalacin-T Gel Post Approval Study
To investigate, in a comparison vs. Acuatim cream (nadifloxacin cream), the efficacy and
 safety of Dalacin T Gel (clindamycin phosphate gel) as a therapeutic medication for acne
 vulgaris in acne vulgaris patients, including children ages 13 and up, in order to clarify
 the clinical positioning of Dalacin T Gel.
Inclusion Criteria:

 -  Acne vulgaris patients found by a investigator to have at least 10 inflammatory
 lesions (papules, pustules) on a portion of either a cheeks or the forehead, with an
 inflammation severity of moderate or worse.

 Exclusion Criteria:

 -  Patients with, for example, acne elastosis, steroidal acne, necrotizing acne, or
 occupational acne.